Wells Fargo Keeps Their Buy Rating on Mastercard (MA)
In a report released yesterday, Donald Fandetti from Wells Fargo reiterated a Buy rating on Mastercard (MA – Research Report), with a price ...
PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the ...
Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...